Save information for later
Sign Up

Learn About Anaplastic Large Cell Lymphoma

What is the definition of Anaplastic Large Cell Lymphoma?
Anaplastic large cell lymphoma (ALCL) is a rare type of Non-Hodgkins lymphoma. Lymphoma is a cancer of the lymph system, part of our immune system. Non-Hodgkins lymphoma involves abnormal growth of white blood cells, either T cells or B cells. Anaplastic large cell lymphoma is an aggressive cancer that usually involves the T-cells. Cancer cells in ALCL can be identified by their appearance under the microscope and by the presence of a tumor marker called CD30 or Ki-1. There are two types of ALCL, a type that affects mainly the skin (cutaneous ALCL) and a type that affects other body organs (systmic ALCL). Systemic ALCL also has two types, ALK-positive (anaplastic lymphoma kinase) and ALK-negative. ALK-positive ALCL occurs more often in children and young adults. ALK-negative ALCL tends to occur in older adults. The symptoms of cutaneous ALCL include red skin lesions that break open and do not heal. Sometimes cutaneous ALCL is also found in the lymph nodes. The symptoms of systemic ALCL include fever, night sweats, and weight loss (B symptoms). The cancer can be found in the bone, soft tissue, spleen, liver and skin. The cause of ALCL is unknown. One type of ALK-negative ALCL has been associated with breast implants. ALCL is diagnosed by a biopsy of the tumor or abnormal skin and examination of the tumor cells under a microscope. Additional testing including PET scans, CT scans, MRI and a bone marrow biopsy can tell doctors if the cancer has spread to other organs.[15060
What are the alternative names for Anaplastic Large Cell Lymphoma?
  • Anaplastic large cell lymphoma
  • ALCL
Who are the top Anaplastic Large Cell Lymphoma Local Doctors?

Duke Lightner Dermatology

11081 Forest Pines Dr, Suite 110, 
Raleigh, NC 
 (70.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Erin Lesesky is a Dermatologist in Raleigh, North Carolina. Dr. Lesesky and is rated as an Advanced provider by MediFind in the treatment of Anaplastic Large Cell Lymphoma. Her top areas of expertise are Mycosis Fungoides, Basal Cell Skin Cancer, Extramammary Paget Disease, and Squamous Cell Skin Carcinoma. Dr. Lesesky is currently accepting new patients.

Radiation Oncology
Radiation Oncology

Duke Health Integrated Practice Inc

40 Duke Medicine Cir, 
Durham, NC 
 (92.0 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Christopher Kelsey is a Radiation Oncologist in Durham, North Carolina. Dr. Kelsey and is rated as an Advanced provider by MediFind in the treatment of Anaplastic Large Cell Lymphoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Kelsey is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Louis F. Diehl
Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Duke Health Integrated Practice Inc

2301 Erwin Rd, 
Durham, NC 
 (92.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Louis Diehl is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Diehl and is rated as an Experienced provider by MediFind in the treatment of Anaplastic Large Cell Lymphoma. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Diehl is currently accepting new patients.

What are the latest Anaplastic Large Cell Lymphoma Clinical Trials?
A Phase 1, Open-label Study to Evaluate SGN-35C in Adults With Advanced Malignancies.

Summary: This clinical trial is studying lymphoma. Lymphoma is a cancer that starts in the blood cells that fight infection. There are several types of lymphoma. This study will enroll people who have classical Hodgkin lymphoma (cHL), peripheral T cell lymphoma (PTCL), or diffuse large B cell lymphoma (DLBCL). This clinical trial uses a drug called SGN-35C . The study drug is in testing and has not been ap...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Using a Modified ALCL99 Regimen for Chinese Children with Newly Diagnosed High-risk Anapestic Large Cell Lymphoma

Summary: A prospective study on the efficacy of modified ALCL99 regimens in the treatment of the current Chinese pediatric and adolescent high-risk ALCL and compared with our historical data.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center